Hepatic lipid peroxidation in hereditary hemochromatosis and alcoholic liver injury

Journal of Laboratory and Clinical Medicine

Volumn 133, Issue 5, 1999, Pages 451-460

  Niemelä, Onni ^a   Parkkila, Seppo ^b   Britton, Robert S ^b   Brunt, Elizabeth ^b   Janney, Christine ^b   Bacon, Bruce ^b  

^a EP Central Hospital Laboratory   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033134774     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90022-7     Document Type: Article

References (41)

1. 1. Nicholls GM, Bacon BR. Hereditary hemochromatosis: Pathogenesis and clinical features of a common disease. Am J Gastroenterol 1989;84:851-62.
2. 2. Powell LW, Burt MJ, Halliday JW, Jazwinska EC. Hemochromatosis: Genetics and pathogenesis. Semin Liver Dis 1996;16:55-63.
3. 3. Bacon BR, Tavill AS. Hemochromatosis and the iron overload syndromes. In: Zakim D, Boyer TD, editors. Hepatology. A textbook of liver disease. 3rd ed. Philadelphia: WB Saunders; 1996. p. 1439-72.
4. 4. Bacon BR, Britton RS. The pathology of hepatic iron overload: A free radical-mediated process? Hepatology 1990;11:127-37.
5. 5. Britton RS. Metal-induced hepatotoxicity. Semin Liver Dis 1996;16:3-12.
6. 6. Kukielka E, Cederbaum AI. Ferritin stimulation of lipid peroxidation by microsomes after chronic ethanol treatment: role of cytochrome P4502EI. Arch Biochem Biophys 1996;332:121-7.
7. 7. Lieber CS. Medical disorders of alcoholism. N Engl J Med 1995;333:1058-65.
8. 8. Chen JJ, Schenker S, Henderson GI. 4-hydroxynonenal levels are enhanced in fetal liver mitochondria by in utero ethanol exposure. Hepatology 1997;25:142-7.
9. 9. Niemelä O, Parkkila S, Ylä-Herttuala S, Halsted C, Lanca A, Israel Y. Covalent protein adducts in the liver as a result of ethanol metabolism and lipid peroxidation. Lab Invest 1994;70:537-46.
10. 10. Haberland ME, Fong D, Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 1988;241:215-8.
11. 11. Palinski W, Rosenfeld ME, Ylä-Herttuala S, Gartner GC, Socher SS, Butler S, et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A 1989;86:1372-6.
12. 12. Paradis V, Kollinger M, Fabre M, Holstege A, Poynard T, Bedossa P. In situ detection of lipid peroxidation by-products in chronic liver diseases. Hepatology 1997;26:135-42.
13. 13. Houglum K, Filip M, Witztum JL, Chojkier M. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload. J Clin Invest 1990;86:1991-8.
14. 14. Parkkila S, Niemelä O, Britton RS, Brown KE, Ylä-Herttuala S, O'Neill R, et al. Vitamin E decreases hepatic levels of aldehyde-derived peroxidation products in rats with iron overload. Am J Physiol 1996;270:G376-84.
15. 15. Tsukamoto H, Horne W, Kamimura S, Niemelä O, Parkkila S, Ylä-Herttuala S, et al. Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 1995;96:620-30.
16. 16. Irving MG, Halliday JW, Powell LW. Association between alcoholism and increased hepatic iron stores. Alcohol Clin Exp Res 1988;12:7-13.
17. 17. Kukielka E, Cederbaum AI. NADPH-and NADH-dependent oxygen radical generation by rat liver nuclei in the presence of redox cycling agents and iron. Arch Biochem Biophys 1990;283:326-33.
18. 18. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
19. 19. Searle J, Kerr JFR, Halliday JW, Powell LW. Iron storage disease. In: MacSween RNM, Anthony PB, Scheues PI, Burt AD, Portmann BC, editors. Pathology of the liver. Edinburgh: Churchill Livingstone; 1994. p. 219.
20. 20. Palinski W, Ylä-Herttuala S, Rosenfeld ME, Butler SW, Socher SA, Parthasarathy S, et al. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 1990;10:325-35.
21. 21. Torrance JD, Bothwell TH. Tissue iron stores. In: Cook JD, editor. Iron. New York: Churchill Livingston; 1980. p. 90-115.
22. 22. Young IS, Trouton TG, Torney JJ, McMaster D, Callender ME, Trimble ER. Antioxidant status and lipid peroxidation in hereditary haemochromatosis. Free Rad Biol Med 1994;16:393-7.
23. 23. Houglum K, Ramm GA, Crawford DHG, Witztum JL, Powell LW, Chojkier M. Excess iron induces hepatic oxidative stress and transforming growth factor β1 in genetic hemochromatosis. Hepatology 1997;26:605-10.
24. 24. Peters TJ, Jones BM, Jacobs A, Wagstaff J. "Free" iron and lipid-peroxidation in the plasma of patients with iron overload. Proteins of iron storage and transport. In: Spik G, Montreuil J, Crichton RR, Mazurier J, editors. New York: Elsevier; 1985. p. 321-4.
25. 25. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Rad Biol Med 1991;11:81-128.
26. 26. Rouach H, Fataccioli V, Gentil M, French SW, Morimoto M, Nordmann R. Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology. Hepatology 1997;25:351-5.
27. 27. Pietrangelo A, Gualdi R, Casalgrandi G, Montosi G, Ventura E. Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents. J Clin Invest 1995;95:1824-31.
28. 28. Parola M, Leonarduzzi G, Biasi F, Albano E, Biocca ME, Poli G, et al. Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis. Hepatology 1992;16:1014-21.
29. 29. Niemelä O, Parkkila S, Ylä-Herttuala S, Villanueva J, Ruebner B, Halsted CH. Sequential acetaldehyde production, lipid peroxidation, and fibrogenesis in micropig model of alcohol-induced liver disease. Hepatology 1995;22:1208-13.
30. 30. Niemelä O, Juvonen J, Parkkila S. Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption. J Clin Invest 1991;87:1367-74.
31. 31. Holstege A, Bedossa P, Poynard T, Kollinger M, Chaput JC, Houglum K, et al. Acetaldehyde-modified epitopes in liver biopsy specimens of alcoholic and non-alcoholic patients: localization and association with progression of liver fibrosis. Hepatology 1994;19:367-74.
32. 32. Mauch TJ, Donohue TM Jr, Zettermann RK, Sorrell MF, Tuma DJ. Covalent binding of acetaldehyde selectively inhibits the catalytic activity of lysine-dependent enzymes. Hepatology 1986;6:263-9.
33. 33. Viitala K, Israel Y, Blake JE, Niemelä O. Serum IgA, IgG, and IgM antibodies directed against acetaldehyde-modified epitopes: relationship to liver disease severity and alcohol consumption. Hepatology 1997;25:1418-24.
34. 34. Clot P, Bellomo G, Tabone M, Aricò S, Albano E. Detection of antibodies against proteins modified by hydroxyethyl free radicals in patients with alcoholic cirrhosis. Gastroenterology 1995;108:201-7.
35. 35. Lin R, Fillenwarth M, Du X. Cytotoxic effect of 7-alpha-hydroxy-4-cholesten-3-one on hepG2 cells: Hypothetical role of acetaldehyde-modified delta-4-3-ketosteroid-5-beta reductase (the 37 kD-liver-protein) in the pathogenesis of alcoholic liver injury in the rat. Hepatology 1998;27:100-7.
36. 36. Moshage H, Casini A, Lieber CS. Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocytes. Hepatology 1990;12:511-8.
37. 37. Parola M, Pinzani M, Casini A, Albano E, Poli G, Gentiliní A, et al. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells. Biochem Biophys Res Commun 1993;194:1044-50.
38. 38. Schiff ER. Hepatitis C and alcohol. Hepatology 1997;26(Suppl 1):39S-42S.
39. 39. George DK, Goldwurm S, MacDonald GA, Cowley LL, Walker NI, Ward PJ, et al. Increased hepatic concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998;114:311-8.
40. 40. French SW. Nutrition in the pathogenesis of alcoholic liver disease. Alcohol Alcohol 1993;28:97-109.
41. 41. Weltman MD, Liddle C, Hall P, Farrell GC. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 1998;27:128-33.